Reactomix has started an ambitious research program in breast cancer
Only in USA, microorganism induced corrosion represents a 3 B loss to the American economy. Reactomix is willing to understand the molecular basis of this process to develop personalized solutions for different industries
Reactomix is seeking partners for the development of personalized cosmetic applications
Reactomix has received approval of the IRB from the Hospital de Cruces & Hospital Galdakao to identify biomarkers of early diagnostic and prognostic in sarcomas.
Reactomix has launched its first >3000 synthetic metabolome microarray to undertake fingerprinting analysis of cell, tissues, biological fluids, etc. from any species
Reactomix has started a project for the selection of strains and optimization of biomanufacturing processes in microalgae.